Hospira

1Q Revenues: $888.7 million (+14%)

1Q Earnings: $65.4 million (loss of $29.4 million 1Q07)

Comments: In the Americas, pharmaceuticals revenues grew was 11% to $462.6 million. However, the "Other Pharmaceuticals" unit, which  
includes injectables and contract revenues, dropped 3% to $121.9  
million. Asia Pacific pharmaceuticals revenue was $49.7 million  
(+58%). 1Q07 loss includes $66.2 million of acquired in-process R&D  
charges related to the Mayne Pharma acquisition.